The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

Because AI technology is constantly evolving, employers must remain flexible, experts say. “A static AI policy will be ...

The subject in this interview: Rasmus Kjaergaard, the CEO of Mindway AI, a company that merges neuroscience, expert ...

Salesforce’s new business simulator is a significant step in developing more capable, agentic AI. Salesforce AI Research ...

Learn what crypto signals are, how to get crypto signals for crypto trading, and which providers and tools can help you make ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...

FSA founder Andrew Cronin breaks down the biggest hiring pitfalls for early-stage companies and explains how a new ...

NEW YORK, NY / ACCESS Newswire / September 5, 2025 / Singapore has taken a bold step forward with the launch of its national ...

That is the essential point. Sustainability and innovation are two forces that will always move forward together. When ...

Attorney Dennis Beaver discusses why some businesses succeed where others fail and some common pitfalls one expert says could ...

The researchers found that when governments try to incentivize early disclosure by promising lower fines, they can make it ...